Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Mason

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Nature Reviews. Clinical Oncology|August 8, 2019
Global Consultation on Cancer Staging: promoting consistent understanding and useJames Brierley, Brian O'Sullivan, Hisao Asamura, et al.
The Lancet. Oncology|March 29, 2023
Promoting cancer prevention through World Cancer Day in NigeriaRuncie C W Chidebe, L Leigh Leibel, Tochukwu C Orjiakor, et al.
Scientific Reports|June 15, 2021
Embedding supervised exercise training for men on androgen deprivation therapy into standard prostate cancer care: a feasibility and acceptability study (the STAMINA trial)Sophie Reale, Rebecca R Turner, Eileen Sutton, et al.
Lancet (London, England)|November 8, 2011
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialPadraig Warde, Malcolm Mason, Keyue Ding, et al.
The Lancet. Oncology|March 13, 2022
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trialDavid Dearnaley, Victoria Hinder, Adham Hijab, et al.
The Lancet. Oncology|February 5, 2019
Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based studyAmy Downing, Penny Wright, Luke Hounsome, et al.
The New England Journal of Medicine|September 15, 2016
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
BJU International|January 5, 2020
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progressionRichard J Bryant, Jon Oxley, Grace J Young, et al.
European Urology Focus|June 20, 2021
Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic ReviewLisa Moris, Giorgio Gandaglia, Antoni Vilaseca, et al.
European Urology Focus|June 29, 2019
Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel RecommendationsThomas Van den Broeck, Roderick C N van den Bergh, Erik Briers, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Nature Reviews. Clinical Oncology|August 8, 2019
Global Consultation on Cancer Staging: promoting consistent understanding and useJames Brierley, Brian O'Sullivan, Hisao Asamura, et al.
The Lancet. Oncology|March 29, 2023
Promoting cancer prevention through World Cancer Day in NigeriaRuncie C W Chidebe, L Leigh Leibel, Tochukwu C Orjiakor, et al.
Scientific Reports|June 15, 2021
Embedding supervised exercise training for men on androgen deprivation therapy into standard prostate cancer care: a feasibility and acceptability study (the STAMINA trial)Sophie Reale, Rebecca R Turner, Eileen Sutton, et al.
Lancet (London, England)|November 8, 2011
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialPadraig Warde, Malcolm Mason, Keyue Ding, et al.
The Lancet. Oncology|March 13, 2022
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trialDavid Dearnaley, Victoria Hinder, Adham Hijab, et al.
The Lancet. Oncology|February 5, 2019
Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based studyAmy Downing, Penny Wright, Luke Hounsome, et al.
The New England Journal of Medicine|September 15, 2016
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
BJU International|January 5, 2020
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progressionRichard J Bryant, Jon Oxley, Grace J Young, et al.
European Urology Focus|June 20, 2021
Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic ReviewLisa Moris, Giorgio Gandaglia, Antoni Vilaseca, et al.
European Urology Focus|June 29, 2019
Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel RecommendationsThomas Van den Broeck, Roderick C N van den Bergh, Erik Briers, et al.
Pageof 8